BackJiangxi Fushine Pharmaceutical , Ltd. Overview

Jiangxi Fushine Pharmaceutical , Ltd. Current Assets

Latest current assets for 300497.SZ: $2.1B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.06B
↑ 34.91% YoYΔ $532.23M vs prior year quarter

Peer trimmed avg / median

Loading

Jiangxi Fushine Pharmaceutical , Ltd. Current Assets History

Loading

Jiangxi Fushine Pharmaceutical , Ltd. vs. peers: Current Assets Comparison

Loading

Jiangxi Fushine Pharmaceutical , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jiangxi Fushine Pharmaceutical , Ltd. (300497.SZ) FAQ

Jiangxi Fushine Pharmaceutical , Ltd. (300497.SZ) currently reports a current assets of $2.1B as of September 2026. That compares with $1.5B in the prior-year period — up 34.9% year over year. Use the charts on this page to explore Jiangxi Fushine Pharmaceutical , Ltd.'s current assets history and peer comparisons.

Jiangxi Fushine Pharmaceutical , Ltd.'s current assets increased from $1.5B to $2.1B — a 34.9% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jiangxi Fushine Pharmaceutical , Ltd. reported $2.1B in current assets as of September 2026. That compares with $1.5B in the prior-year period — up 34.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $2.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jiangxi Fushine Pharmaceutical , Ltd., and consider following 300497.SZ for alerts when major investors trade the stock.

Jiangxi Fushine Pharmaceutical , Ltd. is classified in the Healthcare sector. On current assets, it currently shows $2.1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 300497.SZ with unrelated industries.